解析衰弱中的贫血:炎症作用的探索
该研究纳入208例62-98岁老年住院患者,按Fried衰弱表型分为衰弱前期(68例)和衰弱期(140例),检测铁代谢、炎症和血液学标志物。衰弱期患者贫血患病率更高(84.3% vs 70.6%,p=.021),主成分分析显示仅炎症相关成分与衰弱状态独立相关(OR:2.018,95%CI:1.316-3.094,p=.001)。结论提示衰弱患者的贫血主要由炎症驱动,而非疾病相关或单纯微量营养素缺乏所致。
要点
- 衰弱期老年住院患者贫血患病率显著高于衰弱前期(84.3% vs 70.6%)。
- 炎症相关生物标志物模式与衰弱状态独立相关(OR:2.018,95%CI:1.316-3.094)。
- 大细胞性贫血及血液病理相关成分与衰弱无显著关联。
核心结论
- 衰弱患者的贫血主要由炎症驱动,而非疾病相关或单纯微量营养素缺乏所致。
研究设计与样本
- 纳入208例62-98岁老年住院患者,按Fried衰弱表型分为衰弱前期(n=68)和衰弱期(n=140)。
- 检测铁代谢、炎症(IL-6、IL-10、C反应蛋白)和血液学标志物,采用主成分分析和逻辑回归评估与衰弱的关联。
主要发现
- 衰弱期患者贫血患病率为84.3%,衰弱前期为70.6%,差异有统计学意义(p=.021)。
- 识别出三个主成分:PC1代表炎症,PC2代表大细胞性贫血(维生素B12或叶酸缺乏),PC3代表血液病理。
- 控制年龄、性别、药物数量和共病后,仅PC1与衰弱状态相关(OR:2.018,95%CI:1.316-3.094,p=.001)。
- PC2和PC3与衰弱无显著关联。
关键数值与推荐
- 衰弱前期与衰弱期患者PC1因子得分分别为-0.04(IQR:1.45)和-0.51(IQR:0.87),差异有统计学意义(p<.001)。
临床怎么用
- 对衰弱老年住院患者评估贫血时,应关注炎症相关标志物,而非仅筛查微量营养素缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In older patients, frailty and anemia frequently coexist. However, only few studies have been conducted in older patients with multimorbidity and several overlapping causes of anemia, such as inflammation, inadequate nutrition, or certain pathologies. This analysis aims to decipher potential factors associated with anemia in older hospital patients with frailty. METHODS: Patients (n = 208, age: 62-98 years) were categorized as prefrail (n = 68) and frail (n = 140) using the Fried frailty phenotype. We quantified serum concentrations of markers of iron metabolism (iron, ferritin, transferrin, soluble transferrin receptor, and hepcidin), inflammation (interleukin [IL]-6 and IL-10 C-reactive protein), and hematology (hemoglobin). Principal component analysis was conducted to evaluate biomarker patterns and associations with frailty were assessed with logistic regression analysis. RESULTS: Anemia prevalence was higher in patients with frailty (84.3% vs 70.6%, p = .021). Three principal components (PC1-3) were identified. PC1 was characterized by high factor loadings representing inflammation and factor scores differed between patients with prefrailty and frailty (-0.04 (interquartile range [IQR]: 1.45) vs -0.51 (IQR: 0.87), p < .001]. PC2 represents macrocytic anemia and thus vitamin B12 or folate deficiency, whereas PC3 indicates hematological pathologies. Only PC1 was associated with frailty status when controlled for age, sex, number of drugs, and comorbidities (OR: 2.018, 95% CI: 1.316; 3.094, p = .001). PC2 and PC3 were not associated with frailty. CONCLUSIONS: Our results suggest that anemia in patients with frailty is driven by inflammation rather than being disease-related or solely the result of micronutrient deficiencies.
引用
- Herpich C, Göger L, Faust L, et al. Disentangling Anemia in Frailty: Exploring the Role of Inflammation. J Gerontol A Biol Sci Med Sci. 2024. PMID: 39360829. doi:10.1093/gerona/glae243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。